您的位置：
首页
>
农业专利
>
详情页
COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS
- 专利权人:
- Alnylam Pharmaceuticals; Inc.
- 发明人:
- Novobrantseva, Tatiana,Bettencourt, Brian,Hinkle, Greg,Kotelianski, Victor,Sehgal, Alfica
- 申请号：
- AU2017232114
- 公开号：
- AU2017232114A1
- 申请日:
- 2017.09.21
- 申请国别(地区):
- AU
- 年份:
- 2017
- 代理人:
- 摘要：
- #$%^&*AU2017232114A120171026.pdf#####Abstract The invention relates to double-stranded ribonucleic acid (dsRNA) for inhibiting expression of collagen 1A1 (COL1A1), transforming growth factor beta 1 (TFGP) and/or SMAD homolog 2 and 3 (SMAD2/3) and methods of treating chronic liver disease characterised by liver fibrosis thereof.
- 来源网站：
- 中国工程科技知识中心
- 来源网址：
- http://www.ckcest.cn/home/
